The Federal Trade Commission and four US states are suing a group called WPATH. This group gives medical advice for children.

美國聯邦貿易委員會與四個州政府正起訴一個名為 WPATH 的組織。該組織提供兒童醫療建議。

The government says WPATH gave wrong information. They say WPATH did not tell parents about the dangers of medicine for transgender children. One leader says WPATH wanted money more than safety.

政府表示 WPATH 提供了錯誤資訊。他們稱 WPATH 未告知家長關於跨性別兒童藥物的危險性。一名領導者表示 WPATH 追求金錢勝過安全。

President Trump's government is looking at many medical groups now. They are checking other groups like the American Academy of Pediatrics too.

川普總統的政府目前正在審查許多醫療組織。他們也在檢查像是美國兒科學會等其他組織。

WPATH says their advice is good. They say doctors and science agree with them. WPATH says the government is attacking them for no reason.

WPATH 表示他們的建議是正確的。他們稱醫生和科學界都認同他們的做法。WPATH 表示政府是在毫無理由地攻擊他們。

The two sides are still fighting in court.

雙方目前仍在法庭上對簿公堂。

The Federal Trade Commission (FTC) and four U.S. states have started a lawsuit against the World Professional Association for Transgender Health (WPATH) concerning its medical guidelines for minors.

聯邦貿易委員會 (FTC) 與四個美國州政府已對世界跨性別健康專業人士協會 (WPATH) 提起訴訟，涉及其針對未成年人的醫療指南。

The lawsuit, which includes the states of Alaska, Iowa, Nebraska, and Texas, claims that WPATH shared misleading information about the safety and necessity of medical treatments for transgender minors. These treatments include puberty blockers, hormones, and surgeries. The FTC emphasized that WPATH did not clearly explain the potential side effects and removed age-based recommendations from its standards. FTC Chairman Andrew Ferguson asserted that the organization put financial profit ahead of the health and safety of children.

這項訴訟包括阿拉斯加州、愛荷華州、內布拉斯加州與德州，指稱 WPATH 針對跨性別未成年人醫療處理的安全性與必要性提供了誤導性資訊。這些治療包括青春期阻斷劑、荷爾蒙治療與手術。FTC 強調 WPATH 未能清楚解釋潛在的副作用，並將基於年齡的建議從其標準中刪除。FTC 主席 Andrew Ferguson 主張，該組織將財務利潤置於兒童的健康與安全之上。

This legal action is part of a larger effort by the Trump administration to examine gender-affirming care. Consequently, the FTC has also started investigations into the Endocrine Society and the American Academy of Pediatrics. Previously, in May, a federal judge temporarily stopped an FTC investigation into WPATH after the organization argued that the probe violated its First Amendment right to free speech.

此次法律行動是川普政府審查性別肯定醫療服務之更大努力的一部分。因此，FTC 也開始對內分泌學會與美國兒科學會進行調查。此前在五月，一名聯邦法官暫時停止了 FTC 對 WPATH 的調查，因為該組織主張該調查違反了其在第一修正案中享有的言論自由權。

In response, WPATH maintains that its guidelines are based on scientific standards and expert agreement. They argue that their goal is to provide personalized care for each patient rather than using a one-size-fits-all approach. Furthermore, the organization described the lawsuit as a targeted attack intended to weaken the independence of medical professionals and violate their constitutional rights.

對此，WPATH 主張其指南是基於科學標準與專家共識。他們認為其目標是為每位患者提供個人化照護，而非採取一成不變的方法。此外，該組織將這項訴訟描述為一次有目的的攻擊，旨在削弱醫療專業人士的獨立性並違反其憲法權利。

The legal battle continues as WPATH attempts to defend its clinical standards against the accusations of deception from federal and state authorities.

法律之爭仍在持續，WPATH 試圖在聯邦與州政府的欺騙指控下，捍衛其臨床標準。

The Federal Trade Commission and four U.S. states have filed a lawsuit against the World Professional Association for Transgender Health (WPATH) regarding the dissemination of medical guidelines for minors.

聯邦貿易委員會與四個美國州政府就傳播未成年人醫療指南的問題，對世界跨性別健康專業協會 (WPATH) 提起訴訟。

The litigation, joined by the states of Alaska, Iowa, Nebraska, and Texas, posits that WPATH disseminated deceptive information concerning the efficacy, safety, and necessity of medical interventions for transgender minors, specifically citing puberty blockers, cross-sex hormones, and surgical procedures. Central to the FTC's contention is the assertion that WPATH failed to provide adequate disclosure regarding potential adverse effects and that the organization excised age-based recommendations from its Standards of Care. FTC Chairman Andrew Ferguson characterized the organization's conduct as a prioritization of financial gain over the health and safety of pediatric patients.

此項訴訟由阿拉斯加州、愛荷華州、內布拉斯加州與德州共同參與，主張 WPATH 傳播了關於跨性別未成年人醫療干預（特別是青春期阻斷劑、跨性別激素與手術程序）之功效、安全性與必要性的誤導性資訊。聯邦貿易委員會 (FTC) 主張的核心在於 WPATH 未能就潛在副作用提供足夠披露，且該組織從其「護理標準」中刪除了基於年齡的建議。FTC 主席 Andrew Ferguson 將該組織的行為描述為將經濟利益置於小兒科患者的健康與安全之上。

This legal maneuver occurs within a broader administrative effort by the Trump administration to scrutinize gender-affirming care. The FTC has similarly initiated investigations into the Endocrine Society and the American Academy of Pediatrics, both of which have pursued legal recourse. Prior to this suit, a federal judge granted a temporary injunction in May to block an FTC probe into WPATH, following the organization's claim that such investigations constituted a violation of First Amendment protections.

此次法律行動發生在川普政府審查性別肯定治療之更廣泛行政努力的背景下。FTC 同樣對內分泌學會 (Endocrine Society) 與美國兒科學會 (American Academy of Pediatrics) 展開調查，兩者均已尋求法律救濟。在此次起訴前，一名聯邦法官於 5 月頒布臨時禁令，以阻止 FTC 對 WPATH 的調查，此前該組織聲稱此類調查構成對第一修正案保障的侵害。

In response to these allegations, WPATH maintains that its guidelines are predicated on expert consensus and scientific standards designed to facilitate individualized patient care rather than standardized protocols. The organization has characterized the current legal action as a retaliatory measure and a targeted campaign intended to undermine the independence of professional medical bodies and infringe upon constitutional rights.

針對這些指控，WPATH 主張其指南是基於專家共識與科學標準，旨在促進個體化的患者護理而非標準化方案。該組織將目前的法律行動定調為報復性措施，以及旨在削弱專業醫療團體獨立性並侵犯憲法權利的針對性運動。

The legal dispute remains ongoing as WPATH seeks to defend its clinical standards against federal and state allegations of deception.

法律爭議仍在持續，WPATH 試圖捍衛其臨床標準，以對抗聯邦與各州關於誤導的指控。